Exact Mass: 379.033787

Exact Mass Matches: 379.033787

Found 95 metabolites which its exact mass value is equals to given mass value 379.033787, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   

2-Bromo-5-hydroxy-N-(4-hydroxyphenethyl)-4-methoxy-N-methylbenzamide

2-Bromo-5-hydroxy-N-[2-(4-hydroxyphenyl)ethyl]-4-methoxy-N-methylbenzamide

C17H18BrNO4 (379.04191280000003)


   

6-Thioguanosine monophosphate

{[(2R,3S,4R,5R)-5-(2-amino-6-sulfanylidene-6,9-dihydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5O7PS (379.03515440000007)


6-Thioguanosine monophosphate is a metabolite of tioguanine. Tioguanine, formerly thioguanine, is a drug that is used in the treatment of cancer. It belongs to the family of drugs called antimetabolites. It is a guanine analog. (Wikipedia) Norcodeine

   

8-Oxoguanosine 5-phosphate

8-Oxoguanosine 5-phosphate

C10H14N5O9P (379.0529124)


   

Griseolic acid

5-(6-amino-9H-purin-9-yl)-2-[carboxy(hydroxy)methyl]-6-hydroxy-2H,5H,6H,6aH-furo[3,2-b]furan-2-carboxylic acid

C14H13N5O8 (379.0764098)


   

Methyl 2-(2-acetoxy-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate

Methyl 2-[2-(acetyloxy)-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl]-2-(2-chlorophenyl)acetic acid

C18H18ClNO4S (379.0645018000001)


   

[2,3-e]-1,2-Thiazine-6-sulfonamide 1,1-Dioxide 1

2-methyl-3-[(morpholin-4-yl)methyl]-1,1-dioxo-2H-1lambda6-thieno[2,3-e][1,2]thiazine-6-sulfonamide

C12H17N3O5S3 (379.03303120000004)


   

Cyclopenthiazide

6-chloro-3-(cyclopentylmethyl)-1,1-dioxo-3,4-dihydro-2H-1λ⁶,2,4-benzothiadiazine-7-sulfonamide

C13H18ClN3O4S2 (379.0427218)


C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators

   

Dimethane sulfonate

2-[(4-Formyl-3-methylphenyl)[2-(methanesulphonyloxy)ethyl]amino]ethyl methanesulphonic acid

C14H21NO7S2 (379.0759396)


   

N-(p-Toluenesulfonyl)-L-phenylalanyl Chloromethyl Ketone

N-(5-Chloro-3,4-dioxo-1-phenylpentan-2-yl)-4-methylbenzene-1-sulphonamide

C18H18ClNO4S (379.0645018000001)


   

[(2R,5R)-5-(2-Amino-6-sulfanylidene-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[(2R,5R)-5-(2-Amino-6-sulphanylidene-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphoric acid

C10H14N5O7PS (379.03515440000007)


   
   
   
   

3-(2,3-Dihydro-1H-indol-1-yl)-2-{[5-(trifluoromethyl)-2-pyridyl]sulfonyl}acrylonitrile

3-(2,3-Dihydro-1H-indol-1-yl)-2-{[5-(trifluoromethyl)-2-pyridyl]sulfonyl}acrylonitrile

C17H12F3N3O2S (379.0602288)


   

Pyridinium-3,5-biscarboxylic acid mononucleotide; P2CMN; Pyridin-1-ium-3,5-dicarboxylate mononucleotide; Pyridinium-3,5-biscarboxylate mononucleotide

Pyridinium-3,5-biscarboxylic acid mononucleotide; P2CMN; Pyridin-1-ium-3,5-dicarboxylate mononucleotide; Pyridinium-3,5-biscarboxylate mononucleotide

C12H14NO11P (379.0304464)


   
   
   
   

cyclopenthiazide

cyclopenthiazide

C13H18ClN3O4S2 (379.0427218)


C - Cardiovascular system > C03 - Diuretics > C03A - Low-ceiling diuretics, thiazides > C03AA - Thiazides, plain D045283 - Natriuretic Agents > D004232 - Diuretics > D049993 - Sodium Chloride Symporter Inhibitors C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D049990 - Membrane Transport Modulators

   
   

((4R,5R)-5-(4-Iodophenyl)-2-phenyl-4,5-dihydrooxazol-4-yl)methanol

((4R,5R)-5-(4-Iodophenyl)-2-phenyl-4,5-dihydrooxazol-4-yl)methanol

C16H14INO2 (379.0069254)


   

N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide

N-(p-Hydroxyphenethyl)-N-(2-bromo-5-hydroxy-4-methoxybenzyl)formamide

C17H18BrNO4 (379.04191280000003)


   

2-[3-(2,6-dichlorophenyl)sulfanyl-2,5-dimethylindol-1-yl]acetic acid

2-[3-(2,6-dichlorophenyl)sulfanyl-2,5-dimethylindol-1-yl]acetic acid

C18H15Cl2NO2S (379.020051)


   

2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl [R-(R*,R*)]-aminoacetate

2-[(dichloroacetyl)amino]-3-hydroxy-3-(4-nitrophenyl)propyl [R-(R*,R*)]-aminoacetate

C13H15Cl2N3O6 (379.033787)


   

ETHYL 4-(3,5-DICHLOROPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE

ETHYL 4-(3,5-DICHLOROPHENOXY)-1,3-DIMETHYL-1H-PYRAZOLO[3,4-B]PYRIDINE-5-CARBOXYLATE

C17H15Cl2N3O3 (379.049042)


   

2-(3-BROMO-PHENYL)-6-(4-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

2-(3-BROMO-PHENYL)-6-(4-METHOXY-PHENYL)-PYRAZOLO[1,5-A]PYRIMIDINE

C19H14BrN3O (379.03201740000003)


   

2-[4-(2-phenyl-1,3-thiazol-4-yl)anilino]-1,3-thiazole-4-carboxylic acid

2-[4-(2-phenyl-1,3-thiazol-4-yl)anilino]-1,3-thiazole-4-carboxylic acid

C19H13N3O2S2 (379.0449158)


   

4-[(2E)-2-(8-oxoquinolin-5-ylidene)hydrazinyl]naphthalene-1-sulfonic acid

4-[(2E)-2-(8-oxoquinolin-5-ylidene)hydrazinyl]naphthalene-1-sulfonic acid

C19H13N3O4S (379.0626738000001)


   

sodium,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetate

sodium,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetate

C19H15ClNNaO4 (379.0587260000001)


   

4-(3-(2,5-DIFLUOROPHENYL)-5,5-DIMETHYL-4-OXO-4,5-DIHYDROFURAN-2-YL)BENZENESULFONAMIDE

4-(3-(2,5-DIFLUOROPHENYL)-5,5-DIMETHYL-4-OXO-4,5-DIHYDROFURAN-2-YL)BENZENESULFONAMIDE

C18H15F2NO4S (379.0689814000001)


   

5-[(3-chlorophenyl)azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-(phenylamino)nicotinonitrile

5-[(3-chlorophenyl)azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-(phenylamino)nicotinonitrile

C19H14ClN5O2 (379.08359740000003)


   

3-BROMO-1-(4-[5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]-1,4-DIAZEPAN-1-YL)PROPAN-1-ONE

3-BROMO-1-(4-[5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]-1,4-DIAZEPAN-1-YL)PROPAN-1-ONE

C14H17BrF3N3O (379.0507008)


   

L-689,560

(2R,4S)-4-[[anilino(oxo)methyl]amino]-5,7-dichloro-1,2,3,4-tetrahydroquinoline-2-carboxylic acid

C17H15Cl2N3O3 (379.049042)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists

   

N-cyclopentyl-5-(4-iodophenyl)-2-methylpyrimidin-4-amine

N-cyclopentyl-5-(4-iodophenyl)-2-methylpyrimidin-4-amine

C16H18IN3 (379.05454180000004)


   

N-(TRIISOPROPYLSILYL)-3,4-DIBROMOPYRROLE

N-(TRIISOPROPYLSILYL)-3,4-DIBROMOPYRROLE

C13H23Br2NSi (378.9966398)


   
   
   

Dimethane sulfonate

Dimethane sulfonate

C14H21NO7S2 (379.0759396)


C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

   

Methyl 2-(2-acetoxy-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate

Methyl 2-(2-acetoxy-6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)-2-(2-chlorophenyl)acetate

C18H18ClNO4S (379.0645018000001)


   

4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-((5-nitrothiazol-2-yl)thio)-1H-1,2,4-triazol-5(4H)-one

4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-((5-nitrothiazol-2-yl)thio)-1H-1,2,4-triazol-5(4H)-one

C13H9N5O5S2 (379.0045104)


   
   

2-chloro-N-(7-methyl-9-oxo-2-thioxanthenyl)benzamide

2-chloro-N-(7-methyl-9-oxo-2-thioxanthenyl)benzamide

C21H14ClNO2S (379.04337340000006)


   

2-(4-chlorophenyl)-N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide

2-(4-chlorophenyl)-N-[4-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]phenyl]acetamide

C20H14ClN3O3 (379.0723644000001)


   

2-[[1-(phenylmethyl)-3-indolyl]thio]-N-(2-thiazolyl)acetamide

2-[[1-(phenylmethyl)-3-indolyl]thio]-N-(2-thiazolyl)acetamide

C20H17N3OS2 (379.0812992)


   

3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

C18H14BrN5 (379.04325040000003)


   

3-Bromo-6-Phenyl-N-(Pyrimidin-5-Ylmethyl)imidazo[1,2-A]pyridin-8-Amine

3-Bromo-6-Phenyl-N-(Pyrimidin-5-Ylmethyl)imidazo[1,2-A]pyridin-8-Amine

C18H14BrN5 (379.04325040000003)


   

3-Bromo-5-Phenyl-N-(Pyrimidin-5-Ylmethyl)pyrazolo[1,5-A]pyridin-7-Amine

3-Bromo-5-Phenyl-N-(Pyrimidin-5-Ylmethyl)pyrazolo[1,5-A]pyridin-7-Amine

C18H14BrN5 (379.04325040000003)


   

3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine

C18H14BrN5 (379.04325040000003)


   
   

2-Amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one

2-Amino-5-formylamino-6-(5-phospho-D-ribosylamino)pyrimidin-4(3H)-one

C10H14N5O9P-2 (379.0529124)


   

N-acetyl-D-galactosamine 4,6-disulfate

N-acetyl-D-galactosamine 4,6-disulfate

C8H13NO12S2-2 (378.9879178)


   

p-Nitrophenyl-beta-glucoside 6-phosphate

p-Nitrophenyl-beta-glucoside 6-phosphate

C12H14NO11P-2 (379.0304464)


   

[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(4-nitrophenoxy)oxan-2-yl]methyl phosphate

[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-(4-nitrophenoxy)oxan-2-yl]methyl phosphate

C12H14NO11P-2 (379.0304464)


   

N-Hydroxyguanosine 5-phosphoric acid

N-Hydroxyguanosine 5-phosphoric acid

C10H14N5O9P (379.0529124)


   

4-Cyanobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester

4-Cyanobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester

C19H13N3O4S (379.0626738000001)


   

6-(4-fluoro-1,3-benzodioxol-5-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine

6-(4-fluoro-1,3-benzodioxol-5-yl)-N-(thiophen-2-ylmethyl)-4-quinazolinamine

C20H14FN3O2S (379.0790716)


   

5-[(2,4-dichlorophenoxy)methyl]-N-(2-fluorophenyl)furan-2-carboxamide

5-[(2,4-dichlorophenoxy)methyl]-N-(2-fluorophenyl)furan-2-carboxamide

C18H12Cl2FNO3 (379.0178234)


   

(2-Chloro-5-nitrophenyl)(4-(3-chlorophenyl)piperazin-1-yl)methanone

(2-Chloro-5-nitrophenyl)(4-(3-chlorophenyl)piperazin-1-yl)methanone

C17H15Cl2N3O3 (379.049042)


   

2-[[2-(4-Ethoxy-3-methoxyphenyl)-4-thiazolyl]methylthio]-5-methyl-1,3,4-thiadiazole

2-[[2-(4-Ethoxy-3-methoxyphenyl)-4-thiazolyl]methylthio]-5-methyl-1,3,4-thiadiazole

C16H17N3O2S3 (379.0482862)


   

Methyl 5-chloro-4-{[3-(4-chlorophenyl)acryloyl]amino}-2-methoxybenzoate

Methyl 5-chloro-4-{[3-(4-chlorophenyl)acryloyl]amino}-2-methoxybenzoate

C18H15Cl2NO4 (379.03780900000004)


   

N-[(4-sulfamoylanilino)-sulfanylidenemethyl]-1,3-benzodioxole-5-carboxamide

N-[(4-sulfamoylanilino)-sulfanylidenemethyl]-1,3-benzodioxole-5-carboxamide

C15H13N3O5S2 (379.0296608)


   

[[2-[5-(2-Chlorophenyl)-1-tetrazolyl]-6,8-dioxabicyclo[3.2.1]octan-4-ylidene]amino]thiourea

[[2-[5-(2-Chlorophenyl)-1-tetrazolyl]-6,8-dioxabicyclo[3.2.1]octan-4-ylidene]amino]thiourea

C14H14ClN7O2S (379.0618174)


   

2-(4-chlorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)acetamide

2-(4-chlorophenoxy)-N-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)acetamide

C20H14ClN3O3 (379.0723644000001)


   

2-(2-chlorophenyl)-9-(3-methylphenyl)-8-oxo-7H-purine-6-carboxamide

2-(2-chlorophenyl)-9-(3-methylphenyl)-8-oxo-7H-purine-6-carboxamide

C19H14ClN5O2 (379.08359740000003)


   

isopropyl 4-{[(4-bromo-1-ethyl-1H-pyrazol-5-yl)carbonyl]amino}benzoate

isopropyl 4-{[(4-bromo-1-ethyl-1H-pyrazol-5-yl)carbonyl]amino}benzoate

C16H18BrN3O3 (379.05314580000004)


   

N-[[3-chloro-2-(1-piperidinyl)anilino]-sulfanylidenemethyl]-2-thiophenecarboxamide

N-[[3-chloro-2-(1-piperidinyl)anilino]-sulfanylidenemethyl]-2-thiophenecarboxamide

C17H18ClN3OS2 (379.0579768)


   

[4-[(E)-(pyridine-2-carbonylhydrazinylidene)methyl]phenyl] 2-chlorobenzoate

[4-[(E)-(pyridine-2-carbonylhydrazinylidene)methyl]phenyl] 2-chlorobenzoate

C20H14ClN3O3 (379.0723644000001)


   

1-[2-(4-Methylphenyl)-3-indolizinyl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)thio]ethanone

1-[2-(4-Methylphenyl)-3-indolizinyl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)thio]ethanone

C20H17N3OS2 (379.0812992)


   
   

tetracenomycin D3(1-)

tetracenomycin D3(1-)

C20H11O8- (379.0453906)


A hydroxy monocarboxylic acid anion that is the conjugate base of tetracenomycin F1, obtained by deprotonation of the carboxy group.

   

N-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-1,3-benzodioxole-5-carboxamide

N-[(E)-[5-(4-nitrophenyl)furan-2-yl]methylideneamino]-1,3-benzodioxole-5-carboxamide

C19H13N3O6 (379.08043180000004)


   

methanesulfonic acid [(2R,5R)-2-(6-amino-2-chloro-9-purinyl)-4-hydroxy-5-(hydroxymethyl)-3-oxolanyl] ester

methanesulfonic acid [(2R,5R)-2-(6-amino-2-chloro-9-purinyl)-4-hydroxy-5-(hydroxymethyl)-3-oxolanyl] ester

C11H14ClN5O6S (379.0353294)


   

4-chloro-N-(3-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

4-chloro-N-(3-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

C16H14ClN3O4S (379.03935140000004)


   

2-[[3,4-Dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]amino]acetic acid

2-[[3,4-Dihydroxy-5-(3,4,5-trihydroxybenzoyl)oxybenzoyl]amino]acetic acid

C16H13NO10 (379.0539438)


   

[(3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-phosphonooxyoxan-2-yl] 2-aminobenzoate

[(3R,4S,5R,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-phosphonooxyoxan-2-yl] 2-aminobenzoate

C13H18NO10P (379.0668298)


   

4-chloro-N-(5-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

4-chloro-N-(5-hydroxy-2-methylindol-1-yl)-3-sulfamoylbenzamide

C16H14ClN3O4S (379.03935140000004)


   

4-chloro-N-[(2S)-2-methyl-3-oxo-2H-indol-1-yl]-3-sulfamoylbenzamide

4-chloro-N-[(2S)-2-methyl-3-oxo-2H-indol-1-yl]-3-sulfamoylbenzamide

C16H14ClN3O4S (379.03935140000004)


   

2-(alpha-Furyl)-6-hydroxychromanone para-nitrobenzoate

2-(alpha-Furyl)-6-hydroxychromanone para-nitrobenzoate

C20H13NO7 (379.06919880000004)


   
   

5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate

5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)-1,3-benzothiazol-6-yl hydrogen sulfate

C16H17N3O4S2 (379.0660442)


An aryl sulfate obtained by sulfation of the phenolic hydroxy group of the anti-inflammatory drug, E3040. It is one of the major metabolites of E3040.

   

O-304

O-304

C16H11Cl2N3O2S (378.99490060000005)


O-304 is a first-in-class, orally available pan-AMPK activator, which increases AMPK activity by suppressing the dephosphorylation of pAMPK. O-304 exhibits a great potential as a agent to treat type 2 diabetes (T2D) and associated cardiovascular complications [1][2].

   

Vicagrel

Vicagrel

C18H18ClNO4S (379.0645018000001)


Vicagrel is a potent, safe and orally active antiplatelet agent, which works by irreversibly inhibiting P2Y12 receptor. Vicagrel can be used for the research of blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease[1][2].

   

5- O- nitrosouridine

5-O-nitrosouridine

C12H15ClFN5O6 (379.06948520000003)


{"Ingredient_id": "HBIN011870","Ingredient_name": "5- O- nitrosouridine","Alias": "5-O-nitrosouridine","Ingredient_formula": "C12H15ClFN5O6","Ingredient_Smile": "C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)NC(=O)N(CCCl)N=O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "39659;39162","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

5-bromo-1-[(1s)-1-(dimethylamino)-2-(methylsulfanyl)ethyl]-9h-pyrido[3,4-b]indol-6-ol

5-bromo-1-[(1s)-1-(dimethylamino)-2-(methylsulfanyl)ethyl]-9h-pyrido[3,4-b]indol-6-ol

C16H18BrN3OS (379.0353878)


   

(5r)-12'-methyl-3,4',6',10,12-pentaoxa-12'-azaspiro[tricyclo[7.3.0.0²,⁶]dodecane-5,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-1(9),1',2(6),3'(7'),7,8',13'-heptaene-4,10'-dione

(5r)-12'-methyl-3,4',6',10,12-pentaoxa-12'-azaspiro[tricyclo[7.3.0.0²,⁶]dodecane-5,11'-tricyclo[7.5.0.0³,⁷]tetradecane]-1(9),1',2(6),3'(7'),7,8',13'-heptaene-4,10'-dione

C20H13NO7 (379.06919880000004)


   

(2s,5r,6r,6as)-5-(6-aminopurin-9-yl)-2-[carboxy(hydroxy)methyl]-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

(2s,5r,6r,6as)-5-(6-aminopurin-9-yl)-2-[carboxy(hydroxy)methyl]-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

C14H13N5O8 (379.0764098)


   

(2r,5r,6r,6ar)-5-(6-aminopurin-9-yl)-2-[(s)-carboxy(hydroxy)methyl]-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

(2r,5r,6r,6ar)-5-(6-aminopurin-9-yl)-2-[(s)-carboxy(hydroxy)methyl]-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

C14H13N5O8 (379.0764098)